2.Endometrial Stromal Sarcoma Presenting as Prevesical Mass Mimicking Urachal Tumor.
Seung Il JUNG ; Sang Soo SHIN ; Chan CHOI ; Eu Chang HWANG ; Sun Ouck KIM ; Taek Won KANG
Journal of Korean Medical Science 2009;24(3):529-531
Endometrial stromal sarcoma (ESS) is a mesenchymal neoplasm that usually occurs as a primary tumor of the uterine corpus, but rarely arises in other sites, such as the ovary, pelvic cavity, mesentery, omentum and intestine. Herein, we present a rare case of low-grade ESS presented as prevesical mass. A 60-yr-old woman who had undergone total hysterectomy for endometriosis eleven years ago was presented with incidentally detected prevesical pelvic mass. Since malignant transformation of urachal remnants was possible, the mass was suspected to be a urachal tumor. Extraction of the mass was performed, and the histopathologic diagnosis was low-grade ESS. In summary, prevesical tumor is rare but in patients with endometriosis, we suggest endometriosis and its possible malignant changes should be taken into account in the differential diagnosis of prevesical mass.
Diagnosis, Differential
;
Endometrial Neoplasms/*diagnosis/pathology/ultrasonography
;
Endometriosis/diagnosis
;
Female
;
Humans
;
Hysterectomy
;
Middle Aged
;
Sarcoma, Endometrial Stromal/*diagnosis/pathology/ultrasonography
;
Urachus/abnormalities
;
Urinary Bladder Neoplasms/diagnosis
3.Endometrial cancer arising from atypical complex hyperplasia: The significance in an endometrial biopsy and a diagnostic challenge.
Jung Mi BYUN ; Dae Hoon JEONG ; Young Nam KIM ; En Bee CHO ; Ju Eun CHA ; Moon Su SUNG ; Kyung Bok LEE ; Ki Tae KIM
Obstetrics & Gynecology Science 2015;58(6):468-474
OBJECTIVE: We investigated the features of endometrial hyperplasia with concurrent endometrial cancer that had been diagnosed by endometrial sampling. Further, we attempted to identify an accurate differential diagnostic method. METHODS: We retrospectively studied 125 patients who underwent a diagnostic endometrial biopsy or were diagnosed after the surgical treatment of other gynecological lesions, such as leiomyoma or polyps. Patients were diagnosed between January 2005 and December 2013 at Busan Paik Hospital. Clinical and histopathological characteristics were compared in patients who had atypical endometrial hyperplasia with and without concurrent endometrial cancer. RESULTS: The patients were grouped based on the final pathology reports. One hundred seventeen patients were diagnosed with endometrial hyperplasia and eight patients were diagnosed with endometrioid adenocarcinoma arising from atypical hyperplasia. Of the 26 patients who had been diagnosed with atypical endometrial hyperplasia by office-based endometrial biopsy, eight (30.8%) were subsequently diagnosed with endometrial cancer after they had undergone hysterectomy. The patients with endometrial cancer arising from endometrial hyperplasia were younger (39.1 vs. 47.2 years, P=0.0104) and more obese (body mass index 26.1+/-9.6 vs. 23.8+/-2.8 kg/m2, P=0.3560) than the patients with endometrial hyperplasia. The correlation rate between the pathology of the endometrial samples and the final diagnosis of endometrial hyperplasia was 67.3%. CONCLUSION: In patients with atypical endometrial hyperplasia, the detection of endometrial cancer before hysterectomy can decrease the risk of suboptimal treatment. The accuracy of endometrial sampling for the diagnosis of concurrent endometrial carcinoma was much lower than that for atypical endometrial hyperplasia. Therefore, concurrent endometrial carcinoma should be suspected and surgical intervention should be considered in young or obese patients who present with atypical endometrial hyperplasia.
Biopsy*
;
Busan
;
Carcinoma, Endometrioid
;
Diagnosis
;
Endometrial Hyperplasia
;
Endometrial Neoplasms*
;
Female
;
Humans
;
Hyperplasia*
;
Hysterectomy
;
Leiomyoma
;
Pathology
;
Polyps
;
Retrospective Studies
6.Endometrial cancer occurence five years after breast cancer in BRCA2 mutation patient.
Sang Eun OH ; Soo Hyun KIM ; Mee Seon KIM ; Min Kyu KIM
Obstetrics & Gynecology Science 2015;58(2):175-178
We recently experienced a case of endometrial cancer 5 years after the diagnosis of breast cancer in a patient with a mutation in the BRCA2 gene. A 55-year-old Korean woman who had a past history of breast cancer in her 50s underwent an operation for endometrial cancer. Final pathology confirmed stage Ia, and no adjuvant treatment was performed. After surgery, considering her history of sequential cancer occurrence, genetic counseling was offered. The result showed the BRCA2 variation of unknown significance mutation. This is the first case report of sequential cancers (endometrial and breast) in a patient with a BRCA2 mutation among a Korean population.
Breast Neoplasms*
;
Diagnosis
;
Endometrial Neoplasms*
;
Female
;
Genes, BRCA2
;
Genetic Counseling
;
Humans
;
Middle Aged
;
Pathology
7.Recent advances in pathology of endometrial stromal tumors.
Chinese Journal of Pathology 2006;35(12):752-754
Chromosome Aberrations
;
Diagnosis, Differential
;
Endometrial Neoplasms
;
genetics
;
metabolism
;
pathology
;
Endometrial Stromal Tumors
;
genetics
;
metabolism
;
pathology
;
Female
;
Histone Deacetylases
;
metabolism
;
Humans
;
Immunohistochemistry
;
Neprilysin
;
metabolism
;
Receptors, Oxytocin
;
metabolism
;
Repressor Proteins
;
metabolism
;
Sarcoma, Endometrial Stromal
;
genetics
;
metabolism
;
pathology
;
Uterine Neoplasms
;
metabolism
;
pathology
8.Value of magnetic resonance imaging in preoperative staging of endometrial carcinoma according to International Federation of Gynecology and Obstetrics (2009) staging criteria.
Lixin DU ; Yi LEI ; Dingfu LI ; Xixiong QIU ; Biling LIANG
Journal of Southern Medical University 2012;32(7):1048-1051
OBJECTIVETo analyze the magnetic resonance imaging (MRI) features of endometrial carcinoma and their value in endometrial carcinoma staging according to the International Federation of Gynecology and Obstetrics (FIGO 2009) staging criteria.
METHODSFifty-four patients with pathologically confirmed endometrial carcinoma and complete clinical data underwent preoperative MRI examination. According to FIGO 2009 staging criteria of endometrial carcinoma, the MRI features of the tumor lesions were evaluated for assessment of myometrial invasion and cervical involvement and preoperative staging.
RESULTSThe 54 cases included 27 stage Ia cases, 9 stage Ib cases, 10 stage II cases, 5 stage III cases, and 3 stage IV cases. The total lesion display rate by MRI was 94% (51/54). With an isointensity or hypo-intensity on T1WI, the tumor lesions showed a moderate hyper-intensity on T2WI. In enhanced MRI scanning, the lesions showed a moderate heterogeneous enhancement, which had a lower intensity than the marked enhancement of the myometrium. Combination of T2WI and T1WI in fat suppression sequence enhanced scan had a diagnostic accuracy of 91% (49/54) for myometrial invasion, and the sensitivity, specificity and accuracy of MRI for detecting cervical involvement were 77%, 89%, and 83%, respectively. The accuracy of preoperative MRI-based staging of endometrial carcinoma was 89% (48/54), showing no significant difference from the results of postoperative FIGO 2009 staging and pathological examination (P>0.05).
CONCLUSIONMRI has a high accuracy in the diagnosis, evaluation of myometrial and cervical invasion depth, and preoperative staging of endometrial carcinoma, and serves as an important modality in assisting clinical decisions on the optimal therapeutic protocols and in prognostic estimation.
Adult ; Aged ; Endometrial Neoplasms ; diagnosis ; pathology ; Female ; Humans ; Magnetic Resonance Imaging ; methods ; Middle Aged ; Neoplasm Staging
9.Role of hysteroscopy in the diagnosis of endometrial carcinoma.
Yu WU ; Feng-zhi FENG ; Yang XIANG
Acta Academiae Medicinae Sinicae 2005;27(6):786-789
With the apparently increasing incidence of endometrial carcinoma, much importance has been attached to the early and exact diagnosis of endometrial carcinoma. This article mainly focuses on diagnostic techniques of endometrial carcinoma, especially diagnostic hysteroscopy and its assessment of myometrial invasion as well as stage of endometrial carcinoma. Whether hysteroscopy increases the risk of microscopic extrauterine spread is also discussed in this article.
Endometrial Neoplasms
;
diagnosis
;
pathology
;
therapy
;
Female
;
Humans
;
Hysteroscopy
;
adverse effects
;
methods
;
Neoplasm Staging
10.Endometrioid Adenocarcinoma Arising from Endometriosis of the Uterine Cervix: A Case Report.
Han Moie PARK ; Sang Soo LEE ; Dae Woon EOM ; Gil Hyun KANG ; Sang Wook YI ; Woo Seok SOHN
Journal of Korean Medical Science 2009;24(4):767-771
Endometrioid adenocarcinoma arising from endometriosis of the uterine cervix is rare in premenopausal woman. We describe here a patient with this condition and review the clinical and pathological features of these tumors. A 48-yr-old woman complaining of severe dysmenorrhea was referred for investigation of a pelvic mass. Total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed. Histological examination revealed an endometrioid adenocarcinoma directly adjacent to the endometriosis at the uterine cervix, with a transition observed between endometriosis and endometrioid adenocarcinoma. The patient was diagnosed as having endometrioid adenocarcinoma arising from endometriosis of the uterine cervix and underwent postoperative chemotherapy. Gynecologists and pathologists should be aware of the difficulties associated with a delay in diagnosis of endometrioid adenocarcinoma arising from endometriosis when the tumor presents as a benign looking endometrioma.
Carcinoma, Endometrioid/*diagnosis/etiology/pathology
;
Cervix Uteri/*pathology
;
Diagnosis, Differential
;
Endometrial Neoplasms/*diagnosis/etiology/pathology
;
Endometriosis/complications/*diagnosis/pathology
;
Female
;
Humans
;
Hysterectomy
;
Magnetic Resonance Imaging
;
Middle Aged
;
Ovariectomy